All stock lists
Sera Prognostics, Inc. (NASDAQ:SERA)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
2.04+0.01 (+0.49%)
Insider Score
––Not scored
SERA Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
SERA analyst forecast
Best analysts covering SERA
No firm covering SERA has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
SERA analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Citigroup | Neutral | — | — | Reiterated | 2023-08-10 |
| — | Citigroup | Neutral | — | — | Reiterated | 2022-11-10 |
| — | Berenberg | Buy | — | — | Reiterated | 2022-09-14 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2022-08-29 |
| — | Berenberg | Buy | — | — | Reiterated | 2022-04-27 |
| — | Citigroup | Neutral | — | — | Downgraded | 2022-03-30 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2021-11-19 |
| — | William Blair | Outperform | — | — | Reiterated | 2021-08-09 |
| — | Citigroup | Buy | — | — | Reiterated | 2021-08-09 |
| — | Cowen & Co. | Outperform | — | — | Reiterated | 2021-08-09 |
SERA earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-18 | -0.17 | -0.16 | $32K | $10K |
| 2026-05-06 | -0.16 | -0.17 | $67K | $14K |
| 2026-08-12 | -0.15 | -0.18 | $71K | $30K |
| 2026-11-04 | -0.14 | 0.00 | $75K | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.